HINDSØ, M. et al. Successful Use of a GLP-1 Receptor Agonist as Add-on Therapy to Sulfonylurea in the Treatment of KCNJ11 Neonatal Diabetes. European Journal of Case Reports in Internal Medicine, v. 8, n. 3, 31 Mar.2021.